National Bank of Canada’s bluebird bio BLUE Stock Holding History

National Bank of Canada’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$20	–	3015
2025 Q1	$20	Sell	4 -81,700	-100%	-$491K	﹤0.01%	2775
2024 Q4	$681K	Buy	81,704 +81,700	+2,042,500%	+$714K	﹤0.01%	1367
2024 Q3	$42	Buy	+4	New	+$66	﹤0.01%	2603

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

National Bank of Canada's BLUE Position: Q2 2025 in Review

National Bank of Canada sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 4 shares — an estimated $20 sold.

National Bank of Canada first reported a position in BLUE in Q3 2024 and held it in 3 quarters. The position peaked at $681K in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

National Bank of Canada reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
National Bank of Canada sold 4 bluebird bio shares in Q2 2025, an estimated $20.
National Bank of Canada first reported a position in bluebird bio in Q3 2024 and held it in 3 quarters.
National Bank of Canada's bluebird bio position peaked at $681K in Q4 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.